TY - JOUR AU - Ye, X. S. AU - Yu, C. AU - Aggarwal, A. PY - 2016 DA - 2016// TI - Genomic alterations and molecular subtypes of gastric cancers in asians JO - Chin J Cancer VL - 35 UR - https://doi.org/10.1186/s40880-016-0106-2 DO - 10.1186/s40880-016-0106-2 ID - Ye2016 ER - TY - JOUR AU - Cavalli, F. M. G. AU - Remke, M. AU - Rampasek, L. PY - 2017 DA - 2017// TI - Intertumoral heterogeneity within medulloblastoma subgroups JO - Cancer cell. VL - 31 UR - https://doi.org/10.1016/j.ccell.2017.05.005 DO - 10.1016/j.ccell.2017.05.005 ID - Cavalli2017 ER - TY - JOUR AU - Bolli, N. AU - Avet-Loiseau, H. AU - Wedge, D. C. PY - 2014 DA - 2014// TI - Heterogeneity of genomic evolution and mutational profiles in multiple myeloma JO - Nat Commun. VL - 5 UR - https://doi.org/10.1038/ncomms3997 DO - 10.1038/ncomms3997 ID - Bolli2014 ER - TY - JOUR AU - Schwarz, R. F. AU - Ng, C. K. AU - Cooke, S. L. PY - 2015 DA - 2015// TI - Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis JO - PLoS Med VL - 12 UR - https://doi.org/10.1371/journal.pmed.1001789 DO - 10.1371/journal.pmed.1001789 ID - Schwarz2015 ER - TY - JOUR AU - Izumchenko, E. AU - Chang, X. AU - Brait, M. PY - 2015 DA - 2015// TI - Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA JO - Nat Commun. VL - 6 UR - https://doi.org/10.1038/ncomms9258 DO - 10.1038/ncomms9258 ID - Izumchenko2015 ER - TY - JOUR AU - Ross-Innes, C. S. AU - Becq, J. AU - Warren, A. PY - 2015 DA - 2015// TI - Whole-genome sequencing provides new insights into the clonal architecture of barrett’s esophagus and esophageal adenocarcinoma JO - Nat Genet VL - 47 UR - https://doi.org/10.1038/ng.3357 DO - 10.1038/ng.3357 ID - Ross-Innes2015 ER - TY - JOUR AU - Kim, K. T. AU - Lee, H. W. AU - Lee, H. O. PY - 2015 DA - 2015// TI - Single-cell mrna sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells JO - Genome Biol. VL - 16 UR - https://doi.org/10.1186/s13059-015-0692-3 DO - 10.1186/s13059-015-0692-3 ID - Kim2015 ER - TY - JOUR AU - Kim, H. AU - Zheng, S. AU - Amini, S. S. PY - 2015 DA - 2015// TI - Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution JO - Genome Res VL - 25 UR - https://doi.org/10.1101/gr.180612.114 DO - 10.1101/gr.180612.114 ID - Kim2015 ER - TY - JOUR AU - Nowell, P. C. PY - 1976 DA - 1976// TI - The clonal evolution of tumor cell populations JO - Science VL - 194 UR - https://doi.org/10.1126/science.959840 DO - 10.1126/science.959840 ID - Nowell1976 ER - TY - JOUR AU - Morrissy, A. S. AU - Cavalli, F. M. G. AU - Remke, M. PY - 2017 DA - 2017// TI - Spatial heterogeneity in medulloblastoma JO - Nat Genet VL - 49 UR - https://doi.org/10.1038/ng.3838 DO - 10.1038/ng.3838 ID - Morrissy2017 ER - TY - JOUR AU - Moss, T. J. AU - Qi, Y. AU - Xi, L. PY - 2017 DA - 2017// TI - Comprehensive genomic characterization of upper tract urothelial carcinoma JO - Eur Urol VL - 72 UR - https://doi.org/10.1016/j.eururo.2017.05.048 DO - 10.1016/j.eururo.2017.05.048 ID - Moss2017 ER - TY - JOUR AU - Sun, C. AU - Fang, Y. AU - Yin, J. PY - 2017 DA - 2017// TI - Rational combination therapy with parp and mek inhibitors capitalizes on therapeutic liabilities in ras mutant cancers JO - Sci Transl Med. VL - 9 UR - https://doi.org/10.1126/scitranslmed.aal5148 DO - 10.1126/scitranslmed.aal5148 ID - Sun2017 ER - TY - JOUR AU - Tourneau, C. AU - Delord, J. P. AU - Goncalves, A. PY - 2015 DA - 2015// TI - Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (shiva): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00188-6 DO - 10.1016/S1470-2045(15)00188-6 ID - Tourneau2015 ER - TY - JOUR AU - Stockley, T. L. AU - Oza, A. M. AU - Berman, H. K. PY - 2016 DA - 2016// TI - Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the princess margaret impact/compact trial JO - Genome Med VL - 8 UR - https://doi.org/10.1186/s13073-016-0364-2 DO - 10.1186/s13073-016-0364-2 ID - Stockley2016 ER - TY - JOUR AU - Tannock, I. F. AU - Hickman, J. A. PY - 2016 DA - 2016// TI - Limits to personalized cancer medicine JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMsb1607705 DO - 10.1056/NEJMsb1607705 ID - Tannock2016 ER - TY - JOUR AU - Yu, C. AU - Yu, J. AU - Yao, X. PY - 2014 DA - 2014// TI - Discovery of biclonal origin and a novel oncogene slc12a5 in colon cancer by single-cell sequencing JO - Cell Res VL - 24 UR - https://doi.org/10.1038/cr.2014.43 DO - 10.1038/cr.2014.43 ID - Yu2014 ER - TY - JOUR AU - Ling, S. AU - Hu, Z. AU - Yang, Z. PY - 2015 DA - 2015// TI - Extremely high genetic diversity in a single tumor points to prevalence of non-darwinian cell evolution JO - Proc Natl Acad Sci USA VL - 47 UR - https://doi.org/10.1073/pnas.1519556112 DO - 10.1073/pnas.1519556112 ID - Ling2015 ER - TY - JOUR AU - Yang, Z. AU - Li, C. AU - Fan, Z. PY - 2017 DA - 2017// TI - Single-cell sequencing reveals variants in ARID1A, GPRC5A and MLL2 driving self-renewal of human bladder cancer stem cells JO - Eur Urol VL - 71 UR - https://doi.org/10.1016/j.eururo.2016.06.025 DO - 10.1016/j.eururo.2016.06.025 ID - Yang2017 ER - TY - JOUR AU - Li, C. AU - Wu, S. AU - Yang, Z. PY - 2017 DA - 2017// TI - Single-cell exome sequencing identifies mutations in kcp, loc440040, and loc440563 as drivers in renal cell carcinoma stem cells JO - Cell Res VL - 27 UR - https://doi.org/10.1038/cr.2016.150 DO - 10.1038/cr.2016.150 ID - Li2017 ER - TY - JOUR AU - Liu, S. AU - Cong, Y. AU - Wang, D. PY - 2014 DA - 2014// TI - Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts JO - Stem Cell Rep VL - 2 UR - https://doi.org/10.1016/j.stemcr.2013.11.009 DO - 10.1016/j.stemcr.2013.11.009 ID - Liu2014 ER - TY - JOUR AU - Gupta, P. B. AU - Fillmore, C. M. AU - Jiang, G. PY - 2011 DA - 2011// TI - Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells JO - Cell VL - 146 UR - https://doi.org/10.1016/j.cell.2011.07.026 DO - 10.1016/j.cell.2011.07.026 ID - Gupta2011 ER - TY - JOUR AU - Lim, E. AU - Vaillant, F. AU - Wu, D. PY - 2009 DA - 2009// TI - Aberrant luminal progenitors as the candidate target population for basal tumor development in brca1 mutation carriers JO - Nat Med VL - 15 UR - https://doi.org/10.1038/nm.2000 DO - 10.1038/nm.2000 ID - Lim2009 ER - TY - JOUR AU - Mani, S. A. AU - Guo, W. AU - Liao, M. J. PY - 2008 DA - 2008// TI - The epithelial-mesenchymal transition generates cells with properties of stem cells JO - Cell VL - 133 UR - https://doi.org/10.1016/j.cell.2008.03.027 DO - 10.1016/j.cell.2008.03.027 ID - Mani2008 ER - TY - JOUR AU - Keymeulen, A. AU - Lee, M. Y. AU - Ousset, M. PY - 2015 DA - 2015// TI - Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity JO - Nature VL - 525 UR - https://doi.org/10.1038/nature14665 DO - 10.1038/nature14665 ID - Keymeulen2015 ER - TY - JOUR AU - Koren, S. AU - Reavie, L. AU - Couto, J. P. PY - 2015 DA - 2015// TI - PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours JO - Nature VL - 525 UR - https://doi.org/10.1038/nature14669 DO - 10.1038/nature14669 ID - Koren2015 ER - TY - JOUR AU - McGranahan, N. AU - Swanton, C. PY - 2017 DA - 2017// TI - Clonal heterogeneity and tumor evolution: past, present, and the future JO - Cell VL - 168 UR - https://doi.org/10.1016/j.cell.2017.01.018 DO - 10.1016/j.cell.2017.01.018 ID - McGranahan2017 ER - TY - JOUR AU - Al-Hussaini, H. AU - Subramanyam, D. AU - Reedijk, M. PY - 2011 DA - 2011// TI - Notch signaling pathway as a therapeutic target in breast cancer JO - Mol Cancer Ther VL - 10 UR - https://doi.org/10.1158/1535-7163.MCT-10-0677 DO - 10.1158/1535-7163.MCT-10-0677 ID - Al-Hussaini2011 ER - TY - JOUR AU - King, T. D. AU - Suto, M. J. AU - Li, Y. PY - 2012 DA - 2012// TI - The wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer JO - J Cell Biochem VL - 113 UR - https://doi.org/10.1002/jcb.23350 DO - 10.1002/jcb.23350 ID - King2012 ER - TY - JOUR AU - Korkaya, H. AU - Paulson, A. AU - Iovino, F. PY - 2008 DA - 2008// TI - Her2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion JO - Oncogene VL - 27 UR - https://doi.org/10.1038/onc.2008.207 DO - 10.1038/onc.2008.207 ID - Korkaya2008 ER - TY - JOUR AU - Iliopoulos, D. AU - Hirsch, H. A. AU - Struhl, K. PY - 2009 DA - 2009// TI - An epigenetic switch involving nf-kappab, lin28, let-7 microrna, and il6 links inflammation to cell transformation JO - Cell VL - 139 UR - https://doi.org/10.1016/j.cell.2009.10.014 DO - 10.1016/j.cell.2009.10.014 ID - Iliopoulos2009 ER - TY - JOUR AU - Voss, M. H. AU - Hakimi, A. A. AU - Pham, C. G. PY - 2014 DA - 2014// TI - Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2345 DO - 10.1158/1078-0432.CCR-13-2345 ID - Voss2014 ER - TY - JOUR AU - Zardavas, D. AU - Irrthum, A. AU - Swanton, C. PY - 2015 DA - 2015// TI - Clinical management of breast cancer heterogeneity JO - Nat Rev Clin Oncol VL - 12 UR - https://doi.org/10.1038/nrclinonc.2015.73 DO - 10.1038/nrclinonc.2015.73 ID - Zardavas2015 ER - TY - JOUR AU - Shah, S. P. AU - Roth, A. AU - Goya, R. PY - 2012 DA - 2012// TI - The clonal and mutational evolution spectrum of primary triple-negative breast cancers JO - Nature VL - 486 UR - https://doi.org/10.1038/nature10933 DO - 10.1038/nature10933 ID - Shah2012 ER - TY - JOUR AU - Curtis, C. AU - Shah, S. P. AU - Chin, S. F. PY - 2012 DA - 2012// TI - The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups JO - Nature VL - 486 UR - https://doi.org/10.1038/nature10983 DO - 10.1038/nature10983 ID - Curtis2012 ER - TY - JOUR AU - Meric-Bernstam, F. AU - Brusco, L. AU - Shaw, K. PY - 2015 DA - 2015// TI - Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.60.4165 DO - 10.1200/JCO.2014.60.4165 ID - Meric-Bernstam2015 ER - TY - JOUR AU - Bhola, N. E. AU - Balko, J. M. AU - Dugger, T. C. PY - 2013 DA - 2013// TI - Tgf-beta inhibition enhances chemotherapy action against triple-negative breast cancer JO - J Clin Invest VL - 123 UR - https://doi.org/10.1172/JCI65416 DO - 10.1172/JCI65416 ID - Bhola2013 ER - TY - JOUR AU - Eser, S. AU - Reiff, N. AU - Messer, M. PY - 2013 DA - 2013// TI - Selective requirement of PI3K/PDK1 signaling for kras oncogene-driven pancreatic cell plasticity and cancer JO - Cancer Cell VL - 23 UR - https://doi.org/10.1016/j.ccr.2013.01.023 DO - 10.1016/j.ccr.2013.01.023 ID - Eser2013 ER - TY - JOUR AU - Tovy, A. AU - Spiro, A. AU - McCarthy, R. PY - 2017 DA - 2017// TI - P53 is essential for DNA methylation homeostasis in naive embryonic stem cells, and its loss promotes clonal heterogeneity JO - Genes Dev. VL - 10 UR - https://doi.org/10.1101/gad.299198.117 DO - 10.1101/gad.299198.117 ID - Tovy2017 ER - TY - JOUR AU - Hata, A. N. AU - Niederst, M. J. AU - Archibald, H. L. PY - 2016 DA - 2016// TI - Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition JO - Nat Med VL - 22 UR - https://doi.org/10.1038/nm.4040 DO - 10.1038/nm.4040 ID - Hata2016 ER - TY - JOUR AU - Oxnard, G. R. PY - 2016 DA - 2016// TI - The cellular origins of drug resistance in cancer JO - Nat Med VL - 22 UR - https://doi.org/10.1038/nm.4058 DO - 10.1038/nm.4058 ID - Oxnard2016 ER - TY - JOUR AU - Shaffer, S. M. AU - Dunagin, M. C. AU - Torborg, S. R. PY - 2017 DA - 2017// TI - Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance JO - Nature VL - 546 UR - https://doi.org/10.1038/nature22794 DO - 10.1038/nature22794 ID - Shaffer2017 ER - TY - JOUR AU - McGranahan, N. AU - Swanton, C. PY - 2015 DA - 2015// TI - Biological and therapeutic impact of intratumor heterogeneity in cancer evolution JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2014.12.001 DO - 10.1016/j.ccell.2014.12.001 ID - McGranahan2015 ER - TY - JOUR AU - Sanchez-Laorden, B. AU - Viros, A. AU - Girotti, M. R. PY - 2014 DA - 2014// TI - BRAF inhibitors induce metastasis in ras mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling JO - Sci Signal. VL - 7 UR - https://doi.org/10.1126/scisignal.2004815 DO - 10.1126/scisignal.2004815 ID - Sanchez-Laorden2014 ER - TY - JOUR AU - Lohr, J. G. AU - Stojanov, P. AU - Carter, S. L. PY - 2014 DA - 2014// TI - Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy JO - Cancer Cell VL - 25 UR - https://doi.org/10.1016/j.ccr.2013.12.015 DO - 10.1016/j.ccr.2013.12.015 ID - Lohr2014 ER - TY - JOUR AU - Duncan, J. S. AU - Whittle, M. C. AU - Nakamura, K. PY - 2012 DA - 2012// TI - Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer JO - Cell VL - 149 UR - https://doi.org/10.1016/j.cell.2012.02.053 DO - 10.1016/j.cell.2012.02.053 ID - Duncan2012 ER - TY - JOUR AU - Klempner, S. J. AU - Myers, A. P. AU - Cantley, L. C. PY - 2013 DA - 2013// TI - What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway JO - Cancer Discov VL - 3 UR - https://doi.org/10.1158/2159-8290.CD-13-0063 DO - 10.1158/2159-8290.CD-13-0063 ID - Klempner2013 ER - TY - JOUR AU - Shimizu, T. AU - Tolcher, A. W. AU - Papadopoulos, K. P. PY - 2012 DA - 2012// TI - The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-2381 DO - 10.1158/1078-0432.CCR-11-2381 ID - Shimizu2012 ER - TY - JOUR AU - Mirzoeva, O. K. AU - Das, D. AU - Heiser, L. M. PY - 2009 DA - 2009// TI - Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to mek inhibition JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-3389 DO - 10.1158/0008-5472.CAN-08-3389 ID - Mirzoeva2009 ER - TY - JOUR AU - Hoeflich, K. P. AU - O’Brien, C. AU - Boyd, Z. PY - 2009 DA - 2009// TI - In vivo antitumor activity of mek and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-0317 DO - 10.1158/1078-0432.CCR-09-0317 ID - Hoeflich2009 ER - TY - JOUR AU - Engelman, J. A. AU - Chen, L. AU - Tan, X. PY - 2008 DA - 2008// TI - Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers JO - Nat Med VL - 14 UR - https://doi.org/10.1038/nm.1890 DO - 10.1038/nm.1890 ID - Engelman2008 ER - TY - JOUR AU - Shi, H. AU - Hugo, W. AU - Kong, X. PY - 2014 DA - 2014// TI - Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0642 DO - 10.1158/2159-8290.CD-13-0642 ID - Shi2014 ER - TY - JOUR AU - Larkin, J. AU - Ascierto, P. A. AU - Dreno, B. PY - 2014 DA - 2014// TI - Combined vemurafenib and cobimetinib in BRAF-mutated melanoma JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1408868 DO - 10.1056/NEJMoa1408868 ID - Larkin2014 ER - TY - JOUR AU - Flaherty, K. T. AU - Infante, J. R. AU - Daud, A. PY - 2012 DA - 2012// TI - Combined BRAF and MEK inhibition in melanoma with BRAF v600 mutations JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1210093 DO - 10.1056/NEJMoa1210093 ID - Flaherty2012 ER - TY - JOUR AU - Easwaran, H. AU - Tsai, H. C. AU - Baylin, S. B. PY - 2014 DA - 2014// TI - Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance JO - Mol Cell VL - 54 UR - https://doi.org/10.1016/j.molcel.2014.05.015 DO - 10.1016/j.molcel.2014.05.015 ID - Easwaran2014 ER - TY - JOUR AU - Easwaran, H. AU - Johnstone, S. E. AU - Neste, L. PY - 2012 DA - 2012// TI - A DNA hypermethylation module for the stem/progenitor cell signature of cancer JO - Genome Res VL - 22 UR - https://doi.org/10.1101/gr.131169.111 DO - 10.1101/gr.131169.111 ID - Easwaran2012 ER - TY - JOUR AU - Bernstein, B. E. AU - Mikkelsen, T. S. AU - Xie, X. PY - 2006 DA - 2006// TI - A bivalent chromatin structure marks key developmental genes in embryonic stem cells JO - Cell VL - 125 UR - https://doi.org/10.1016/j.cell.2006.02.041 DO - 10.1016/j.cell.2006.02.041 ID - Bernstein2006 ER - TY - JOUR AU - Azuara, V. AU - Perry, P. AU - Sauer, S. PY - 2006 DA - 2006// TI - Chromatin signatures of pluripotent cell lines JO - Nat Cell Biol VL - 8 UR - https://doi.org/10.1038/ncb1403 DO - 10.1038/ncb1403 ID - Azuara2006 ER - TY - JOUR AU - Azad, N. AU - Zahnow, C. A. AU - Rudin, C. M. PY - 2013 DA - 2013// TI - The future of epigenetic therapy in solid tumours–lessons from the past JO - Nat Rev Clin Oncol VL - 10 UR - https://doi.org/10.1038/nrclinonc.2013.42 DO - 10.1038/nrclinonc.2013.42 ID - Azad2013 ER - TY - JOUR AU - Baylin, S. B. AU - Jones, P. A. PY - 2011 DA - 2011// TI - A decade of exploring the cancer epigenome—biological and translational implications JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3130 DO - 10.1038/nrc3130 ID - Baylin2011 ER - TY - JOUR AU - Kreso, A. AU - Dick, J. E. PY - 2014 DA - 2014// TI - Evolution of the cancer stem cell model JO - Cell Stem Cell VL - 14 UR - https://doi.org/10.1016/j.stem.2014.02.006 DO - 10.1016/j.stem.2014.02.006 ID - Kreso2014 ER - TY - JOUR AU - Jensen, P. B. AU - Holm, B. AU - Sorensen, M. PY - 1997 DA - 1997// TI - In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin JO - Br J Cancer VL - 75 UR - https://doi.org/10.1038/bjc.1997.154 DO - 10.1038/bjc.1997.154 ID - Jensen1997 ER - TY - JOUR AU - Hill, B. T. PY - 1986 DA - 1986// TI - Potential of continuous tumour cell lines for establishing patterns of cross-resistance and collateral sensitivity in vitro JO - Drugs Exp Clin Res VL - 12 ID - Hill1986 ER - TY - JOUR AU - Zhao, B. AU - Sedlak, J. C. AU - Srinivas, R. PY - 2016 DA - 2016// TI - Exploiting temporal collateral sensitivity in tumor clonal evolution JO - Cell VL - 165 UR - https://doi.org/10.1016/j.cell.2016.01.045 DO - 10.1016/j.cell.2016.01.045 ID - Zhao2016 ER - TY - JOUR PY - 2015 DA - 2015// TI - The molecular taxonomy of primary prostate cancer JO - Cell VL - 163 UR - https://doi.org/10.1016/j.cell.2015.10.025 DO - 10.1016/j.cell.2015.10.025 ID - ref64 ER - TY - JOUR AU - Varghese, A. M. AU - Berger, M. F. PY - 2014 DA - 2014// TI - Advancing clinical oncology through genome biology and technology JO - Genome Biol VL - 15 UR - https://doi.org/10.1186/s13059-014-0427-x DO - 10.1186/s13059-014-0427-x ID - Varghese2014 ER - TY - JOUR PY - 2013 DA - 2013// TI - Comprehensive molecular characterization of clear cell renal cell carcinoma JO - Nature VL - 499 UR - https://doi.org/10.1038/nature12222 DO - 10.1038/nature12222 ID - ref66 ER - TY - JOUR PY - 2014 DA - 2014// TI - Comprehensive molecular characterization of urothelial bladder carcinoma JO - Nature VL - 507 UR - https://doi.org/10.1038/nature12965 DO - 10.1038/nature12965 ID - ref67 ER - TY - JOUR PY - 2013 DA - 2013// TI - Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia JO - New Eng J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1301689 DO - 10.1056/NEJMoa1301689 ID - ref68 ER - TY - JOUR AU - Kandoth, C. AU - Schultz, N. PY - 2013 DA - 2013// TI - Integrated genomic characterization of endometrial carcinoma JO - Nature VL - 497 UR - https://doi.org/10.1038/nature12113 DO - 10.1038/nature12113 ID - Kandoth2013 ER - TY - JOUR AU - Jamal-Hanjani, M. AU - Hackshaw, A. AU - Ngai, Y. PY - 2014 DA - 2014// TI - Tracking genomic cancer evolution for precision medicine: the lung tracerx study JO - PLoS Biol VL - 12 UR - https://doi.org/10.1371/journal.pbio.1001906 DO - 10.1371/journal.pbio.1001906 ID - Jamal-Hanjani2014 ER - TY - JOUR AU - Jamal-Hanjani, M. AU - Wilson, G. A. AU - Horswell, S. PY - 2016 DA - 2016// TI - Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw037 DO - 10.1093/annonc/mdw037 ID - Jamal-Hanjani2016 ER - TY - JOUR AU - Gerlinger, M. AU - Rowan, A. J. AU - Horswell, S. PY - 2012 DA - 2012// TI - Intratumor heterogeneity and branched evolution revealed by multiregion sequencing JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1113205 DO - 10.1056/NEJMoa1113205 ID - Gerlinger2012 ER - TY - JOUR AU - Jamal-Hanjani, M. AU - Wilson, G. A. AU - McGranahan, N. PY - 2017 DA - 2017// TI - Tracking the evolution of non-small-cell lung cancer JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1616288 DO - 10.1056/NEJMoa1616288 ID - Jamal-Hanjani2017 ER - TY - JOUR AU - Werner, H. M. AU - Mills, G. B. AU - Ram, P. T. PY - 2014 DA - 2014// TI - Cancer systems biology: a peek into the future of patient care? JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.6 DO - 10.1038/nrclinonc.2014.6 ID - Werner2014 ER - TY - JOUR AU - Du, W. AU - Elemento, O. PY - 2015 DA - 2015// TI - Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies JO - Oncogene VL - 34 UR - https://doi.org/10.1038/onc.2014.291 DO - 10.1038/onc.2014.291 ID - Du2015 ER - TY - JOUR AU - Iorio, F. AU - Knijnenburg, T. A. AU - Vis, D. J. PY - 2016 DA - 2016// TI - A landscape of pharmacogenomic interactions in cancer JO - Cell VL - 166 UR - https://doi.org/10.1016/j.cell.2016.06.017 DO - 10.1016/j.cell.2016.06.017 ID - Iorio2016 ER - TY - JOUR AU - Bhang, H. E. AU - Ruddy, D. A. AU - Krishnamurthy Radhakrishna, V. PY - 2015 DA - 2015// TI - Studying clonal dynamics in response to cancer therapy using high-complexity barcoding JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3841 DO - 10.1038/nm.3841 ID - Bhang2015 ER - TY - JOUR AU - Enriquez-Navas, P. M. AU - Kam, Y. AU - Das, T. PY - 2016 DA - 2016// TI - Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer JO - Sci Transl Med. VL - 8 UR - https://doi.org/10.1126/scitranslmed.aad7842 DO - 10.1126/scitranslmed.aad7842 ID - Enriquez-Navas2016 ER - TY - JOUR AU - McGranahan, N. AU - Furness, A. J. AU - Rosenthal, R. PY - 2016 DA - 2016// TI - Clonal neoantigens elicit t cell immunoreactivity and sensitivity to immune checkpoint blockade JO - Science VL - 351 UR - https://doi.org/10.1126/science.aaf1490 DO - 10.1126/science.aaf1490 ID - McGranahan2016 ER - TY - JOUR AU - Misale, S. AU - Bozic, I. AU - Tong, J. PY - 2015 DA - 2015// TI - Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers JO - Nat Commun. VL - 6 UR - https://doi.org/10.1038/ncomms9305 DO - 10.1038/ncomms9305 ID - Misale2015 ER - TY - JOUR AU - Shaw, A. T. AU - Friboulet, L. AU - Leshchiner, I. PY - 2016 DA - 2016// TI - Resensitization to crizotinib by the lorlatinib ALK resistance mutation L1198f JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1508887 DO - 10.1056/NEJMoa1508887 ID - Shaw2016 ER - TY - JOUR AU - Amirouchene-Angelozzi, N. AU - Swanton, C. AU - Bardelli, A. PY - 2017 DA - 2017// TI - Tumor evolution as a therapeutic target JO - Cancer Discov. VL - 7 UR - https://doi.org/10.1158/2159-8290.CD-17-0343 DO - 10.1158/2159-8290.CD-17-0343 ID - Amirouchene-Angelozzi2017 ER - TY - JOUR AU - Qin, Z. AU - Ljubimov, V. A. AU - Zhou, C. PY - 2016 DA - 2016// TI - Cell-free circulating tumor DNA in cancer JO - Chin J Cancer. VL - 35 UR - https://doi.org/10.1186/s40880-016-0092-4 DO - 10.1186/s40880-016-0092-4 ID - Qin2016 ER - TY - JOUR AU - Siravegna, G. AU - Bardelli, A. PY - 2014 DA - 2014// TI - Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance JO - Genome Biol VL - 15 UR - https://doi.org/10.1186/s13059-014-0449-4 DO - 10.1186/s13059-014-0449-4 ID - Siravegna2014 ER - TY - JOUR AU - Mateo, J. AU - Gerlinger, M. AU - Rodrigues, D. N. PY - 2014 DA - 2014// TI - The promise of circulating tumor cell analysis in cancer management JO - Genome Biol VL - 15 UR - https://doi.org/10.1186/s13059-014-0448-5 DO - 10.1186/s13059-014-0448-5 ID - Mateo2014 ER - TY - JOUR AU - Ding, L. AU - Ley, T. J. AU - Larson, D. E. PY - 2012 DA - 2012// TI - Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing JO - Nature VL - 481 UR - https://doi.org/10.1038/nature10738 DO - 10.1038/nature10738 ID - Ding2012 ER - TY - JOUR AU - Chen, G. AU - Mulla, W. A. AU - Kucharavy, A. PY - 2015 DA - 2015// TI - Targeting the adaptability of heterogeneous aneuploids JO - Cell VL - 160 UR - https://doi.org/10.1016/j.cell.2015.01.026 DO - 10.1016/j.cell.2015.01.026 ID - Chen2015 ER -